Mundidol (Morphine Sulfate)

• Morphine Sulfate is an opioid analgesic used to manage pain across several clinical contexts.
• Moderate to severe acute pain: provides rapid analgesia for sudden, intense pain episodes.
• Postoperative pain: helps control pain following surgical procedures.
• Cancer pain: alleviates persistent pain associated with malignant disease.

• Morphine Sulfate exerts its analgesic effect by acting as a full agonist at mu‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, leading to hyperpolarization of neurons and decreased transmission of nociceptive signals. The result is diminished perception of pain and altered emotional response to painful stimuli.

Morphine Sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: light‑headed sensation.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing.
• Severe hypotension: marked drop in blood pressure.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Dependence or withdrawal: signs of physical or psychological dependence.
• Sedation leading to impaired cognition: profound drowsiness affecting mental function.

When prescribing Morphine Sulfate, clinicians should observe several safety considerations to minimize risk.

• Assess pain severity: confirm that pain is moderate to severe before initiating therapy.
• Evaluate respiratory function: avoid use in patients with compromised breathing.
• Review concomitant CNS depressants: limit combined use with alcohol, benzodiazepines, or other opioids.
• Monitor for signs of dependence: observe for misuse, addiction, or withdrawal symptoms.
• Adjust dose in renal or hepatic impairment: consider reduced dosing or increased monitoring.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Morphine Sulfate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Other opioids: additive respiratory depression and sedation.
• CNS depressants (e.g., benzodiazepines, barbiturates): heightened risk of profound sedation and respiratory compromise.
• MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase morphine plasma levels.
• CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce analgesic effect.
• Anticholinergic agents: may exacerbate constipation.